Cinven is reviewing strategic options for laboratory-services company Synlab International GmbH including a potential sale, people with knowledge of the matter said.
The private equity firm has been speaking with potential advisers and could start a sale process early next year, the people said, asking not to be identified because the information is private. Cinven plans to seek a valuation of about 5.5 billion euros ($6 billion) including debt for Augsburg, Germany-based Synlab, one of the people said.
A sale of Synlab would likely attract other private equity firms, the people said. No final decision has been made, and Cinven could elect to keep the business, the people said. A spokeswoman for Cinven declined to comment, while Synlab didn’t answer phone calls seeking comment.
Cinven first invested in Synlab in June 2015, buying a majority stake from fellow private equity firm BC Partners for about 1.7 billion euros, Bloomberg News reported at the time. It combined the business with Labco SA, which it agreed to buy earlier that year for 1.2 billion euros.
Synlab, led by Chief Executive Officer Mathieu Floreani, also counts Novo A/S and Ontario Teachers’ Pension Plan as minority investors, according to its website. It operates across more than 40 countries, handling more than 500 million clinical tests annually, according to Synlab’s website.
Cinven also owns stakes in retailer Kurt Geiger and German drugmaker Stada Arzneimittel AG, according to its website.
The sale plan comes at a time when Cinven’s rival Apax Partners is also weighing a sale of diagnostic services business Unilabs. The buyout firm is working with advisers at Rothschild & Co. to look at options for the business, people familiar with the matter said last week.
Source: Bloomberg
Can’t stop reading? Read more
HSG plans continuation fund valuing ByteDance at up to $370bn
HSG plans continuation fund valuing ByteDance at up to $370bn HSG is preparing a continuation vehicle that would value ByteDance at up to $370bn, highlighting the growing use of secondary structures to extend exposure to high-performing private assets, Reuters...
Healthcare private equity hits record $190bn as large deals and exits rebound
Healthcare private equity hits record $190bn as large deals and exits rebound Global healthcare private equity set a new record in 2025, with deal value reaching about $191bn as large transactions and exits returned in force, according to Bain & Company....
Warburg Pincus closes $3bn financial services fund despite PE fundraising slowdown
Warburg Pincus closes $3bn financial services fund despite PE fundraising slowdown Warburg Pincus has raised $3bn for its latest financial services fund, bucking a broader slowdown in private equity fundraising and reinforcing its long-standing focus on the sector....